Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alternative spliced transcripts as cancer markers.

O L Caballero1, S J de Souza, R R Brentani

  • 1Ludwig Institute for Cancer Research, São Paulo, Brazil.

Disease Markers
|October 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Signal and Time Resolved Information Experiment (SATIRE): An NMR Supersequence for Monitoring Complex Environmental and Biological Processes without <sup>13</sup>C Enrichment.

Analytical chemistry·2025
Same author

Pooled prevalence of lymphopenia in all-cause hospitalisations and association with infection: a systematic review and meta-analysis.

BMC infectious diseases·2023
Same author

Environmental metabolomics uncovers oxidative stress, amino acid dysregulation, and energy impairment in Daphnia magna with exposure to industrial effluents.

Environmental research·2023
Same author

Diagnosing ventilator-associated pneumonia (VAP) in UK NHS ICUs: the perceived value and role of a novel optical technology.

Diagnostic and prognostic research·2022
Same author

Donor monocyte-derived macrophages promote human acute graft-versus-host disease.

The Journal of clinical investigation·2020
Same author

Undifferentiated febrile illnesses in South Sudan: a case series from Operation TRENTON from June to August 2017.

BMJ military health·2020
Same journal

Correction to "Estrogen Protects against Renal Ischemia-Reperfusion Injury by Regulating Th17/Treg Cell Immune Balance".

Disease markers·2026
Same journal

RETRACTION: miR-127-5p Targets JAM3 to Regulate Ferroptosis, Proliferation, and Metastasis in Malignant Meningioma Cells.

Disease markers·2026
Same journal

RETRACTION: Thyroxine Alleviates Energy Failure, Prevents Myocardial Cell Apoptosis, and Protects against Doxorubicin-Induced Cardiac Injury and Cardiac Dysfunction via the LKB1/AMPK/mTOR Axis in Mice.

Disease markers·2026
Same journal

RETRACTION: Kartogenin Induced Adipose-Derived Stem Cell Exosomes Enhance the Chondrogenic Differentiation Ability of Adipose-Derived Stem Cells.

Disease markers·2026
Same journal

Correction to "KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells".

Disease markers·2026
Same journal

RETRACTION: Antiresistin Neutralizing Antibody Alleviates Doxorubicin-Induced Cardiac Injury in Mice.

Disease markers·2026
See all related articles

Alternative splicing diversifies eukaryotic transcripts, expanding protein diversity and potentially explaining organism complexity. This process is implicated in cancer and may offer novel cancer markers.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Eukaryotic messenger RNAs (mRNAs) are initially transcribed with intronic sequences.
  • Introns are removed, and exons are joined through splicing to create mature mRNAs.
  • Alternative splicing generates transcript diversity from a limited gene set.

Purpose of the Study:

  • To explore the role of alternative splicing in expanding protein repertoire.
  • To investigate the significance of alternative splicing in cancer-associated genes.
  • To assess the potential of alternatively spliced transcripts as cancer biomarkers.

Main Methods:

  • Analysis of mRNA processing pathways.
  • Identification of alternatively spliced gene products.

Related Experiment Videos

  • Comparison of splicing patterns in normal versus tumor tissues.

    • Main Results:

    • Alternative splicing significantly expands the proteome, potentially explaining eukaryotic complexity.
    • Over 50% of human genes are alternatively spliced.
    • Cancer-associated genes like CD44 and WT1 exhibit alternative splicing.
    • Splicing variations are observed during tumor progression and may drive tumorigenesis.

    Conclusions:

    • Alternative splicing is a key mechanism for generating proteomic diversity.
    • Aberrant alternative splicing plays a role in cancer development.
    • Alternatively spliced transcripts show promise as sensitive and specific cancer markers due to differential usage in tumor versus normal tissues.